Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)
Status:
Recruiting
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
A prospective, open label, controlled, randomized, double arm, multi-center study to assess
the efficacy and safety of CLBS12 in patients with critical limb ischemia (CLI) due to
arteriosclerosis obliterans (ASO) with a single arm sub-study to assess the safety and
potential efficacy of CLBS12 in patients with CLI due to Buerger's Disease (BD).